Sustained efficacy of natalizumab in the treatment of relapsing-remitting multiple sclerosis independent of disease activity and disability at baseline: real-life data from a Swiss cohort.

Sustained efficacy of natalizumab in the treatment of relapsing-remitting multiple sclerosis independent of disease activity and disability at baseline: real-life data from a Swiss cohort.

Item
http://www.wikidata.org/entity/Q34154060
Safety and Efficacy of Natalizumab in Japanese Patients with Relapsing-Remitting Multiple Sclerosis: Open-Label Extension Study of a Phase 2 Trial.Long-term safety and effectiveness of natalizumab redosing and treatment in the STRATA MS Study.Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme results.Clinical effects of natalizumab on multiple sclerosis appear early in treatment courseNatalizumab in multiple sclerosis: discontinuation, progressive multifocal leukoencephalopathy and possible use in children.Intervening to reduce the risk of future disability from multiple sclerosis: are we there yet?Disability Progression After Switching from Natalizumab to Fingolimod or Interferon Beta/Glatiramer Acetate Therapies: A NARCOMS Analysis.Use of natalizumab in patients with active relapsing-remitting multiple sclerosis in Kuwait.
P2860

Sustained efficacy of natalizumab in the treatment of relapsing-remitting multiple sclerosis independent of disease activity and disability at baseline: real-life data from a Swiss cohort.

Item
http://www.wikidata.org/entity/Q34154060
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Sustained efficacy of natalizu ...... life data from a Swiss cohort.
@ast
Sustained efficacy of natalizu ...... life data from a Swiss cohort.
@en
Sustained efficacy of natalizu ...... life data from a Swiss cohort.
@nl
type
label
Sustained efficacy of natalizu ...... life data from a Swiss cohort.
@ast
Sustained efficacy of natalizu ...... life data from a Swiss cohort.
@en
Sustained efficacy of natalizu ...... life data from a Swiss cohort.
@nl
prefLabel
Sustained efficacy of natalizu ...... life data from a Swiss cohort.
@ast
Sustained efficacy of natalizu ...... life data from a Swiss cohort.
@en
Sustained efficacy of natalizu ...... life data from a Swiss cohort.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Sustained efficacy of natalizu ...... -life data from a Swiss cohort
@en
P2093
P304
P31
P356
10.1097/WNF.0B013E31824644E6
P433
P478
P50
P577
P698
P921